Trials / Completed
CompletedNCT02011386
Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis
Improved Monitoring and Prediction of Clinical Response and Disease Course During Golimumab Therapy of Patients With Axial Spondyloarthritis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 53 (actual)
- Sponsor
- Professor Mikkel Østergaard · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The study investigates different criteria for remission based on MRI and circulating biomarkers for inflammation, cartilage, connective tissue and bone turnover in patients with axial spondyloarthritis treated with Golimumab. Furthermore, the study also investigates factors that affect disease activity, function and participation by use of different questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Treatment |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2017-02-14
- Completion
- 2017-02-14
- First posted
- 2013-12-13
- Last updated
- 2020-08-17
- Results posted
- 2020-08-17
Locations
6 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02011386. Inclusion in this directory is not an endorsement.